Eyes might benefit from low-dose aspirin

December 2, 2009 A new study by Harvard University researchers found what they described as a modest benefit for aspirin in preventing age-related macular degeneration, also known as AMD.

Doctors followed nearly 40,000 women as part of a study on heart disease and cancer.

None of the women had AMD. They were randomly assigned to take either low-dose aspirin or a placebo. Over the next 10 years, researchers reported an 18 percent lower risk for AMD among those who took aspirin.

The study is reported in this month's issue of Ophthalmology.